Gastrointestinal: Immune-related sclerosing cholangitis with pembrolizumab: Imaging and histological features

被引：3
|
作者：
Suzuki, N. [1 ]
Ikeda, Y. [1 ]
Ono, M. [1 ]
Ohmori, G. [1 ]
Maeda, M. [1 ]
机构：
[1] Steel Mem Muroran Hosp, Dept Gastroenterol, Muroran, Hokkaido, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 37卷 / 09期
关键词：
D O I：
10.1111/jgh.15797
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1652 / 1652
页数：1
相关论文
共 50 条
  • [31] Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab
    Baarslag, Manuel A.
    Heimovaara, Joosje H.
    Borgers, Jessica S. W.
    van Aerde, Koen J.
    Koenen, Hans J. P. M.
    Smeets, Ruben L.
    Buitelaar, Pauline L. M.
    Pluim, Dick
    Vos, Shoko
    Henriet, Stefanie S. V.
    de Groot, Jan Willem B.
    van Grotel, Martine
    Rosing, Hilde
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    Haanen, John B. A. G.
    Amant, Frederic
    Gierenz, Nicole
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (19): : 1790 - 1796
  • [32] Atypical extended immune-related neutropenia in patient treated with pembrolizumab
    Laurain, Pierre-Antoine
    Landrin, Terence
    Souidi, Sami
    Beuzeboc, Philippe
    Scotte, Florian
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 130 : 269 - 271
  • [33] Standardized Histological Evaluation of Primary Sclerosing Cholangitis (PSC): Relationship of Histological Features to Laboratory Findings and Outcome
    Kleiner, D. E.
    Brunt, E. M.
    Lindor, K. D.
    Talwalkar, J. A.
    [J]. MODERN PATHOLOGY, 2013, 26 : 405A - 405A
  • [34] Standardized Histological Evaluation of Primary Sclerosing Cholangitis (PSC): Relationship of Histological Features to Laboratory Findings and Outcome
    Kleiner, D. E.
    Brunt, E. M.
    Lindor, K. D.
    Talwalkar, J. A.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 405A - 405A
  • [35] Renal Immune-related Adverse Event of Pembrolizumab Masked by Pemetrexed
    Nagase, Koya
    Murai, Yukari
    Yokoyama-Kokuryo, Waka
    Nagasaka, Toru
    Sato, Yuki
    Watanabe, Tsuyoshi
    Ito, Yuki
    Nagase, Fumika
    Fujita, Yoshiro
    [J]. INTERNAL MEDICINE, 2024, 63 (02) : 265 - 270
  • [36] Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension
    Acar, Caner
    Sahin, Gokhan
    Yuksel, Haydar Cagatay
    Karaca, Burcak
    [J]. JOURNAL OF CHEMOTHERAPY, 2024,
  • [37] Pembrolizumab-caused polyradiculoneuropathy as an immune-related adverse event
    Kurashige, Takashi
    Mito, Mineyo
    Yamamoto, Hideki
    Sugiura, Tomohito
    Onoe, Takashi
    Kuraoka, Kazuya
    Nakano, Kikuo
    Torii, Tsuyoshi
    [J]. NEUROPATHOLOGY, 2021, 41 (04) : 266 - 272
  • [38] Immune-related adverse events after a single dose of pembrolizumab
    Vos, Hanne
    Lambein, Kathleen
    Wildiers, Hans
    Punie, Kevin
    Smeets, Ann
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 148 : 92 - 94
  • [39] Standardized histological evaluation of Primary Sclerosing Cholangitis (PSC): Relationship of histological features to hallmark lesions of PSC
    Kleiner, David E.
    Brunt, Elizabeth M.
    Lindor, Keith D.
    Talwalkar, Jayant
    [J]. HEPATOLOGY, 2012, 56 : 1137A - 1138A
  • [40] Progression from early to advanced stage of immune-related cholangitis
    Hagiwara, Satoru
    Yoshida, Takeshi
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Aoki, Tomoko
    Morita, Masahiro
    Cishina, Hirokazu
    Komeda, Yoriaki
    Yoshida, Akihiro
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    Kudo, Masatoshi
    [J]. HEPATOLOGY RESEARCH, 2022, 52 (10) : 888 - 892
12345